Rzetelny Adam, Zeller Barbara, Miller Nicholas, City Kathy Egan, Kirsh Kenneth L, Passik Steven D
Millennium Health, 16980 Via Tazon, San Diego, CA 92127 USA ; Millennium Research Institute, San Diego, CA USA.
Housing Enterprise for the Less Privileged/Project Samaritan Inc (HELP/PSI), New York, NY USA.
Int J Ment Health Addict. 2016;14:64-80. doi: 10.1007/s11469-015-9569-7. Epub 2015 Jul 21.
We conducted a psychotherapeutic examination of the use of definitive drug testing (liquid chromatography with tandem mass spectrometry) in the treatment of substance use disorders (SUD). Employing a generic qualitative method (Caelli et al. in (2), 2003; Merriam, 2009) we asked SUD counselors to provide narratives about cases where drug testing had revealed new or unexpected information about clients' drug-taking behaviors. Semi-structured interviews with 12 SUD counselors were conducted by phone and analyzed for themes derived from the literature. These counselors reported many new positive drug tests in clients previously believed to be adherent with treatment. Key themes assessed in counselors' narratives included initial client denial that was often followed by later acknowledgement of relapse and increased motivation, at times presenting new opportunities for clients to engage in treatment and enhance the therapeutic alliance. These results suggest that definitive drug testing can be used in a non-stigmatizing and therapeutic manner.
我们对在物质使用障碍（SUD）治疗中使用确定性药物检测（液相色谱-串联质谱法）进行了心理治疗学检查。采用通用定性方法（Caelli等人，见（2），2003年；Merriam，2009年），我们要求SUD咨询师提供有关药物检测揭示了客户吸毒行为新的或意外信息的案例叙述。通过电话对12名SUD咨询师进行了半结构化访谈，并分析了从文献中得出的主题。这些咨询师报告了许多此前被认为坚持治疗的客户出现新的药物检测阳性结果。咨询师叙述中评估的关键主题包括客户最初的否认，随后往往是对复发的承认和动力的增强，有时为客户提供了参与治疗和加强治疗联盟的新机会。这些结果表明，确定性药物检测可以以无污名化和治疗性的方式使用。
